ABS logo

Arctic Bioscience AS Stock Price

OB:ABS Community·NOK 81.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

ABS Share Price Performance

NOK 3.04
-0.56 (-15.56%)
NOK 3.04
-0.56 (-15.56%)
Price NOK 3.04

ABS Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk and slightly overvalued.

6 Risks
0 Rewards

Arctic Bioscience AS Key Details

NOK 42.6m

Revenue

NOK 29.1m

Cost of Revenue

NOK 13.6m

Gross Profit

NOK 54.6m

Other Expenses

-NOK 41.0m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Aug 27, 2026
-1.52
31.83%
-96.27%
35.4%
View Full Analysis

About ABS

Founded
2011
Employees
22
CEO
Christer Valderhaug
WebsiteView website
www.arctic-bioscience.com

Arctic Bioscience AS, a clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific. The company is developing HRO350, a novel oral drug which is in phase IIb for the treatment of mild-to-moderate psoriasis. It also sells nutraceuticals as intermediary and finished goods products under the ROMEGA brand name. Arctic Bioscience AS was incorporated in 2011 and is headquartered in Ørsta, Norway.

Recent ABS News & Updates

Recent updates

No updates